Oxford University Press, The Journal of Clinical Endocrinology & Metabolism, 4(98), p. 1711-1717, 2013
DOI: 10.1210/jc.2012-3931
SAGE Publications, Annals of Clinical Biochemistry, 4(50), p. 388-389, 2013
DOI: 10.1177/0004563213488059a
Full text: Download
Objective: The aims of the study were to analyze whether there is an association between serum PTH and the prevalence of vertebral fractures and its possible dependence on vitamin D status, and to assess the influence of serum 25-hydroxyvitamin D (25OHD) in the relationship between PTH and bone mineral density (BMD) or bone turnover markers (BTMs). Design, Participants, and Setting: A total of 820 postmenopausal women were recruited after excluding those with any known condition that could influence serum PTH levels, except for a possible low serum 25OHD. Serum PTH and 25OHD concentrations, as well as vertebral fracture prevalence, BMD, and BTM (CTX and PINP) values were recorded. Serum PTH levels were divided into tertiles, and women were grouped into those in the highest tertile (58 pg/ml) and those below. Serum 25OHD levels were stratified in 3 categories (20, 20 –30, and 30 ng/ml).